Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols

被引:6
|
作者
Budai, Bettina Katalin [1 ]
Stollmayer, Robert [1 ]
Ronaszeki, Aladar David [1 ]
Kormendy, Borbala [1 ]
Zsombor, Zita [1 ]
Palotas, Lorinc [1 ]
Fejer, Bence [1 ]
Szendroi, Attila [2 ]
Szekely, Eszter [3 ]
Maurovich-Horvat, Pal [1 ]
Kaposi, Pal Novak [1 ]
机构
[1] Semmelweis Univ, Fac Med, Med Imaging Ctr, Dept Radiol, Budapest, Hungary
[2] Semmelweis Univ, Fac Med, Dept Urol, Budapest, Hungary
[3] Semmelweis Univ, Fac Med, Dept Pathol Forens & Insurance Med, Budapest, Hungary
关键词
renal cell carcinoma; computed tomography; radiomics analysis; texture analysis; machine learning; artificial intelligence; TEXTURE ANALYSIS; KIDNEY CANCER; SUBTYPES; PAPILLARY; FEATURES; CLASSIFICATION; INFORMATION; DIAGNOSIS; SYSTEM; IMAGES;
D O I
10.3389/fmed.2022.974485
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThis study aimed to construct a radiomics-based machine learning (ML) model for differentiation between non-clear cell and clear cell renal cell carcinomas (ccRCC) that is robust against institutional imaging protocols and scanners. Materials and methodsPreoperative unenhanced (UN), corticomedullary (CM), and excretory (EX) phase CT scans from 209 patients diagnosed with RCCs were retrospectively collected. After the three-dimensional segmentation, 107 radiomics features (RFs) were extracted from the tumor volumes in each contrast phase. For the ML analysis, the cases were randomly split into training and test sets with a 3:1 ratio. Highly correlated RFs were filtered out based on Pearson's correlation coefficient (r > 0.95). Intraclass correlation coefficient analysis was used to select RFs with excellent reproducibility (ICC >= 0.90). The most predictive RFs were selected by the least absolute shrinkage and selection operator (LASSO). A support vector machine algorithm-based binary classifier (SVC) was constructed to predict tumor types and its performance was evaluated based-on receiver operating characteristic curve (ROC) analysis. The "Kidney Tumor Segmentation 2019" (KiTS19) publicly available dataset was used during external validation of the model. The performance of the SVC was also compared with an expert radiologist's. ResultsThe training set consisted of 121 ccRCCs and 38 non-ccRCCs, while the independent internal test set contained 40 ccRCCs and 13 non-ccRCCs. For external validation, 50 ccRCCs and 23 non-ccRCCs were identified from the KiTS19 dataset with the available UN, CM, and EX phase CTs. After filtering out the highly correlated and poorly reproducible features, the LASSO algorithm selected 10 CM phase RFs that were then used for model construction. During external validation, the SVC achieved an area under the ROC curve (AUC) value, accuracy, sensitivity, and specificity of 0.83, 0.78, 0.80, and 0.74, respectively. UN and/or EX phase RFs did not further increase the model's performance. Meanwhile, in the same comparison, the expert radiologist achieved similar performance with an AUC of 0.77, an accuracy of 0.79, a sensitivity of 0.84, and a specificity of 0.69. ConclusionRadiomics analysis of CM phase CT scans combined with ML can achieve comparable performance with an expert radiologist in differentiating ccRCCs from non-ccRCCs.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Targeted therapies for non-clear renal cell carcinoma
    Eric A. Singer
    Gennady Bratslavsky
    W. Marston Linehan
    Ramaprasad Srinivasan
    Targeted Oncology, 2010, 5 : 119 - 129
  • [22] Non-Clear Cell Renal Cell Carcinoma, Part 1: Histology
    Valenca, Loana B.
    Hirsch, Michelle S.
    Choueiri, Toni K.
    Harshman, Lauren C.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (05) : 308 - 313
  • [23] Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options
    Ahrens, Marit
    Scheich, Sebastian
    Hartmann, Arndt
    Bergmann, Lothar
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (03) : 128 - 135
  • [24] Non-Clear Cell Renal Cell Carcinoma, Part 2: Therapy
    Valenca, Loana B.
    Hirsch, Michelle S.
    Choueiri, Toni K.
    Harshman, Lauren C.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (06) : 383 - 391
  • [25] Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
    Sepe, Pierangela
    Ottini, Arianna
    Pircher, Chiara Carlotta
    Franza, Andrea
    Claps, Melanie
    Guadalupi, Valentina
    Verzoni, Elena
    Procopio, Giuseppe
    CANCERS, 2021, 13 (15)
  • [26] Targeted therapies for non-clear renal cell carcinoma
    Singer, Eric A.
    Bratslavsky, Gennady
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    TARGETED ONCOLOGY, 2010, 5 (02) : 119 - 129
  • [27] Targeted therapies and the treatment of non-clear cell renal cell carcinoma
    Bellmunt, J.
    Dutcher, J.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1730 - 1740
  • [28] Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
    Heng, Daniel Y. C.
    Bukowski, Ronald M.
    ONCOLOGY REVIEWS, 2007, 1 (03) : 170 - 176
  • [29] Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma
    Dong Xiao-qiu
    Shen Yi
    Xu Li-wei
    Xu Chun-mei
    Bi Wei
    Wang Xiao-min
    CHINESE MEDICAL JOURNAL, 2009, 122 (10) : 1179 - 1183
  • [30] The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature
    Ventriglia, Jole
    Passarelli, Anna
    Pisano, Carmela
    Cecere, Sabrina Chiara
    Rossetti, Sabrina
    Feroce, Florinda
    Forte, Miriam
    Casartelli, Chiara
    Tambaro, Rosa
    Pignata, Sandro
    Perversi, Fabio
    Di Napoli, Marilena
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 188